BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 29044442)

  • 1. Concurrent mental and substance use disorders in Canada.
    Khan S
    Health Rep; 2017 Aug; 28(8):3-8. PubMed ID: 29044442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delays in making initial treatment contact after the first onset of mental health disorders in the Argentinean Study of Mental Health Epidemiology.
    Stagnaro JC; Cia AH; Vommaro H; Sustas S; Vázquez N; Serfaty E; Kessler RC; Benjet C
    Epidemiol Psychiatr Sci; 2019 Apr; 28(2):240-250. PubMed ID: 29540248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Twelve-month treatment of psychiatric disorders in the South African Stress and Health Study (World Mental Health Survey Initiative).
    Seedat S; Stein DJ; Herman A; Kessler R; Sonnega J; Heeringa S; Williams S; Williams D
    Soc Psychiatry Psychiatr Epidemiol; 2008 Nov; 43(11):889-97. PubMed ID: 18677573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does rural residence limit access to mental health services?
    Hardy CL; Kelly KD; Voaklander D
    Rural Remote Health; 2011; 11(4):1766. PubMed ID: 22039894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Service Use and Unmet Needs for Substance Use and Mental Disorders in Canada.
    Urbanoski K; Inglis D; Veldhuizen S
    Can J Psychiatry; 2017 Aug; 62(8):551-559. PubMed ID: 28616935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment for illegal drug use disorders: the role of comorbid mood and anxiety disorders.
    Melchior M; Prokofyeva E; Younès N; Surkan PJ; Martins SS
    BMC Psychiatry; 2014 Mar; 14():89. PubMed ID: 24670230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delay of first treatment of mental and substance use disorders in Mexico.
    Borges G; Wang PS; Medina-Mora ME; Lara C; Chiu WT
    Am J Public Health; 2007 Sep; 97(9):1638-43. PubMed ID: 17666703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Common and unique risk factors and comorbidity for 12-month mood and anxiety disorders among Canadians.
    Meng X; D'Arcy C
    Can J Psychiatry; 2012 Aug; 57(8):479-87. PubMed ID: 22854030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of mood, anxiety, and substance use disorders with occupational status and disability in a community sample.
    el-Guebaly N; Currie S; Williams J; Wang J; Beck CA; Maxwell C; Patten SB
    Psychiatr Serv; 2007 May; 58(5):659-67. PubMed ID: 17463347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mental health service use: comparing people who served in the military or received Veterans' Affairs benefits and the general population.
    McGuire A; Dobson A; Mewton L; Varker T; Forbes D; Wade D
    Aust N Z J Public Health; 2015 Dec; 39(6):524-9. PubMed ID: 26337053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Policy initiative to improve access to psychological services for people with affective and anxiety disorders: population-level analysis.
    Harris MG; Burgess PM; Pirkis JE; Slade TN; Whiteford HA
    Br J Psychiatry; 2011 Feb; 198(2):99-108. PubMed ID: 21160055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comorbidity in Australia: findings of the 2007 National Survey of Mental Health and Wellbeing.
    Teesson M; Slade T; Mills K
    Aust N Z J Psychiatry; 2009 Jul; 43(7):606-14. PubMed ID: 19530017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Substance use disorders comorbid with mood and anxiety disorders in the Australian general population.
    Prior K; Mills K; Ross J; Teesson M
    Drug Alcohol Rev; 2017 May; 36(3):317-324. PubMed ID: 27324816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Temporal sequencing of lifetime mood disorders in relation to comorbid anxiety and substance use disorders--findings from the Netherlands Mental Health Survey and Incidence Study.
    de Graaf R; Bijl RV; Spijker J; Beekman AT; Vollebergh WA
    Soc Psychiatry Psychiatr Epidemiol; 2003 Jan; 38(1):1-11. PubMed ID: 12563553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiological associations between gambling behavior, substance use & mood and anxiety disorders.
    el-Guebaly N; Patten SB; Currie S; Williams JV; Beck CA; Maxwell CJ; Wang JL
    J Gambl Stud; 2006; 22(3):275-87. PubMed ID: 17009123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Co-occurring mental illness, substance use disorders, and antisocial personality disorder among clients of forensic mental health services.
    Ogloff JR; Talevski D; Lemphers A; Wood M; Simmons M
    Psychiatr Rehabil J; 2015 Mar; 38(1):16-23. PubMed ID: 25799303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Twelve-month mental health service use in six countries of the Americas: A regional report from the World Mental Health Surveys.
    Borges G; Aguilar-Gaxiola S; Andrade L; Benjet C; Cia A; Kessler RC; Orozco R; Sampson N; Stagnaro JC; Torres Y; Viana MC; Medina-Mora ME
    Epidemiol Psychiatr Sci; 2019 Aug; 29():e53. PubMed ID: 31452485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Personality correlates of outpatient mental health service utilization: findings from the U.S. national comorbidity survey.
    McWilliams LA; Cox BJ; Enns MW; Clara IP
    Soc Psychiatry Psychiatr Epidemiol; 2006 May; 41(5):357-63. PubMed ID: 16565922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. First-incidence of DSM-IV mood, anxiety and substance use disorders and its determinants: results from the Netherlands Mental Health Survey and Incidence Study-2.
    de Graaf R; ten Have M; Tuithof M; van Dorsselaer S
    J Affect Disord; 2013 Jul; 149(1-3):100-7. PubMed ID: 23399481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Age of onset of mental disorders and use of mental health services: needs, opportunities and obstacles.
    de Girolamo G; Dagani J; Purcell R; Cocchi A; McGorry PD
    Epidemiol Psychiatr Sci; 2012 Mar; 21(1):47-57. PubMed ID: 22670412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.